DOI: 10.4244/EIJV9SSA1

Welcome to PCR London Valves 2013

Martyn Thomas1, MD, PhD; Stephan Windecker2, MD

Welcome to this dedicated EuroIntervention Supplement, which accompanies PCR London Valves 2013, the 4th edition of PCR London Valves. Once more the meeting is at the Queen Elizabeth Conference Centre in the heart of London. This year we have taken the opportunity of using the whole of the conference centre in order to accommodate the growing number of attendees.

The spirit of the conference is unchanged. This meeting is dedicated to transcatheter valve “Heart Teams” and we hope all the various members of these Heart Teams are represented amongst the attendees. Much of the focus of the meeting will be based on practical demonstrations (live and taped cases) and the sharing of collective experience. There will be very few lectures in the Main Auditorium, which will be dedicated to Live Demonstrations. This year the three live transmission centres will be St Thomas’ Hospital in London, Bern University Hospital, Switzerland, and Asklepios Klinik St Georg, Hamburg, Germany. We hope to be able to demonstrate live the implantation of all of the available transcatheter valve devices. In addition, we have been delighted by the overwhelming response to our “call for cases” and abstracts. There was a 40% increase in submissions, and many of these have been selected for presentation throughout the meeting.

In the second major room of the meeting there will be a number of important didactic sessions, which will cover the hottest topics in transcatheter valve therapies in 2013. We are confident that this Supplement reflects these important sessions and will give you a true “flavour” of the meeting. The topics and review articles include TAVI vascular access routes, including the emergence of the transaortic approach, low-flow low-gradient aortic stenosis, TAVI for aortic regurgitation, TAVI with coronary artery disease and mitral regurgitation, paravalvular leak after TAVI, valve-in-valve procedures, stroke protection during TAVI, cost-effectiveness of TAVI and many aspects of transcatheter mitral valve interventions.

There are a number of new devices, which have been commercially released or are close to being released. In addition, there are a number of innovative technologies, which are at an earlier phase in their development (either at the benchtop stage or in animal trials). Many of these devices will be described during the meeting and are highlighted in this Supplement in the Innovations/New Technologies section.

An important feature of PCR London Valves is the interactive nature of the meeting. A specific room will be dedicated to interactive educative sessions. These will include “Learning” sessions on TAVI, transseptal puncture and transcatheter interventions for both mitral stenosis and mitral regurgitation. In addition, there will be “Learning pathways” on valve-in-valve therapies and treatment of mitral regurgitation. We would urge you to attend these sessions and share your experience with other attendees.

Finally, we would like to thank everyone who has contributed to the meeting and once more: Welcome to London!

Volume 9 Supplement S
Sep 15, 2013
Volume 9 Supplement S
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV10SUA1 Sep 27, 2014
Welcome to PCR London Valves 2014
Thomas M and Windecker S
free

10.4244/EIJV14SABA1 Sep 7, 2018
Welcome to PCR London Valves 2018: 10th Anniversary Edition
Barbanti M et al
free

10.4244/EIJV8SQA1 Sep 30, 2012
Welcome to PCR London Valves 2012
Thomas M and Windecker S
free

10.4244/EIJV10I7A136 Nov 20, 2014
PCR London Valves: a very special year
Windecker S et al
free

10.4244/EIJV12I9A179 Oct 20, 2016
EAPCI: the home for the world’s valvular community
Haude M
free

10.4244/EIJV12SYA1 Sep 18, 2016
Welcome to PCR London Valves 2016: back to the UK
Tamburino C et al
free
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved